Orchid Pharma
BSE 524372
4 stories, newest first.
- Orchid Pharma signs licensing and supply agreement with Libra for Exblifep across nine Latin American markets
- Board approves enabling resolution to explore raising up to Rs. 600 Crores
- Board approves enabling resolution to explore raising up to Rs. 600 crore
- Board meeting on October 20, 2026 to consider and evaluate options for raising funds
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.